Research Article
Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection
Table 1
Demographic and clinical characteristics of the study population.
| Age (years) | Mean (SD): 46.96 (9.61) | Median range: 46 (41–52) |
| Sex (%) | Male: 219 (73) | Female: 81 (27) |
| Ethnic background (%) | White: 253 (84.3) | Hispanic: 27 (9) | Black: 9 (3) |
| Risk group (%) | IDU: 110 (36.7) | MSM: 106 (35.3) | Heterosexual: 74 (24.7) | Others: 7 (3.3) |
| HAART (%) | Yes: 283 (95.3) | No: 17 (4.7) | NNRTI: 130 (43.3) | PI: 165 (55) | TDF: 173 (57.5) | ABC: 63 (21) |
| Serum 25(OH)D category (%) | <10 ng/mL: 84 (28) | <20 ng/mL: 186 (62) | >20 ng/mL: 114 (38) |
| PTH > 65 pg/mL (%) | Yes: 137 (45.7) | No: 163 (54.3) |
|
|